| Active ingredient (INN) | Aprepitant |
|---|---|
| Brand names | Arx, Aprepitant Accord |
| ATC level 5 | A04AD12 |
| ATC level 4 | A04AD |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Juno Pharmaceuticals Pty Ltd, Medicianz Healthcare Pty Ltd, Southern Cross Pharma Pty Ltd, AFT Pharmaceuticals Pty Ltd +4 more |
| Registrations on file | 26 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Arx | 80 mg | — | 🇦🇺 AU | — | Active |
| Arx | 165 mg | — | 🇦🇺 AU | — | Active |
| FOSAPREPITANT MSN fosaprepitant | 150 mg | — | 🇦🇺 AU | — | Active |
| FOSAPREPITANT JUNO fosaprepitant | 150 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| FOSAPREPITANT MEDICIANZ fosaprepitant | 150 mg | — | 🇦🇺 AU | Medicianz Healthcare Pty Ltd | Active |
| FOSAPREPITANT MEDSURGE fosaprepitant | 150 mg | — | 🇦🇺 AU | Medicianz Healthcare Pty Ltd | Active |
| Rjic | 80 mg | — | 🇦🇺 AU | — | Active |
| Dwrn | 40 mg | — | 🇦🇺 AU | — | Active |
| Dwrn | 80 mg | — | 🇦🇺 AU | — | Active |
| Dwrn | 165 mg | — | 🇦🇺 AU | — | Active |
| Rjic | 40 mg | — | 🇦🇺 AU | — | Active |
| Rjic | 165 mg | — | 🇦🇺 AU | — | Active |
| Rmb | 165 mg | — | 🇦🇺 AU | Southern Cross Pharma Pty Ltd | Active |
| FOSAPREPITANT-AFT fosaprepitant | 150 mg | — | 🇦🇺 AU | AFT Pharmaceuticals Pty Ltd | Active |
| Fosaprepitant Dimeglumine | 150mg/5mL | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |